Location History:
- Palo Alto, CA (US) (1976 - 1978)
- Menlo Park, CA (US) (1977 - 1983)
Company Filing History:
Years Active: 1976-1983
Title: Kenneth E. Rubenstein: A Pioneer in Enzyme Immunoassays
Introduction
Kenneth E. Rubenstein, an accomplished inventor based in Menlo Park, California, has made significant contributions to the field of enzyme immunoassays. With an impressive portfolio of 15 patents, Rubenstein continues to innovate within the realm of biological assays, showcasing his expertise and dedication to advancing scientific knowledge.
Latest Patents
Rubenstein's latest patents demonstrate his focus on enhancing the sensitivity and reliability of immunoassays. One such patent is the **β-D-Galactosidase Conjugate for Enzyme Immunoassays**, which involves the conjugation of β-D-Galactosidase with analytes. This method allows for a quantitative determination of the analyte by comparing the resulting enzymatic activity with standard assay media.
Another notable patent is the **Enzyme Amplification Compounds for Assays for Androgens**. This innovative approach employs a modified enzyme to amplify the detection of specific organic materials. By utilizing receptors specific to ligands and forming an 'enzyme-bound-ligand', Rubenstein's method provides an exceedingly sensitive means of assaying for ligands, greatly enhancing detection capabilities in various biological applications.
Career Highlights
Rubenstein's work is closely associated with Syva Company, a leader in developing diagnostic assays. His innovative approaches and patented technologies have had a lasting impact on the company's product offerings and have paved the way for advancements in clinical diagnostics.
Collaborations
Throughout his career, Rubenstein has collaborated with notable colleagues, including Edwin F. Ullman and Richard K. Leute. These partnerships have fostered a rich exchange of ideas and have contributed to the development of cutting-edge technologies within the field of biochemistry and immunoassays.
Conclusion
Kenneth E. Rubenstein stands out as a significant figure in the realm of enzyme immunoassays. His patents and collaborations continue to shape the landscape of biological assays, ensuring that advancements in this field persist. With a commitment to innovation, Rubenstein's work not only benefits the scientific community but also enhances diagnostic capabilities worldwide.